A Study in Healthy People to Test if Taking Different Formulations of BI 425809 Tablets Influences the Amount of BI 425809 in the Blood

NCT03817476 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: iCF1(T1) 25 milligram BI 425809
DRUG: iCF2(T2) 25 milligram BI 425809
DRUG: TF2(R) 25 milligram BI 425809

Sponsor

Boehringer Ingelheim